Trade FLNA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Filana Therapeutics, Inc. (FLNA) is trading at US$0.73, up 0.83% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$46.42M. Over the past 52 weeks, FLNA has traded between US$0.67 and US$4.98. On Syfe you can trade FLNA with $0 commission and add it to your watchlist.
| Previous close | US$0.72 |
|---|---|
| Market cap | US$46.42M |
| 52-week range | US$0.67 – US$4.98 |
| Volume | 122.71K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Filana Therapeutics, Inc.
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Year: 2000
Filana Therapeutics, Inc. (FLNA) stock is trading at US$0.73, +0.83% from the previous close of US$0.72.
The market cap for Filana Therapeutics, Inc. (FLNA) stock is approximately US$46.42M.
The 52-week high for Filana Therapeutics, Inc. (FLNA) stock is US$4.98.
The 52-week low for Filana Therapeutics, Inc. (FLNA) stock is US$0.67.
Filana Therapeutics, Inc. (FLNA) does not currently pay a dividend.
Stay on top of FLNA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
